Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 46

1.

Changes in serum levels of bone morphogenic protein 4 and inflammatory cytokines after bariatric surgery in severely obese korean patients with type 2 diabetes.

Kim MK, Jang EH, Hong OK, Chun HJ, Yoo SJ, Baek KH, Kim W, Kim EK, Song KH, Kwon HS.

Int J Endocrinol. 2013;2013:681205. doi: 10.1155/2013/681205.

2.

Visceral obesity is a negative predictor of remission of diabetes 1 year after bariatric surgery.

Kim MK, Lee HC, Kwon HS, Baek KH, Kim EK, Lee KW, Song KH.

Obesity (Silver Spring). 2011 Sep;19(9):1835-9. doi: 10.1038/oby.2011.205.

3.

Effects of bariatric surgery on metabolic and nutritional parameters in severely obese Korean patients with type 2 diabetes: A prospective 2-year follow up.

Kim MK, Kim W, Kwon HS, Baek KH, Kim EK, Song KH.

J Diabetes Investig. 2014 Mar 23;5(2):221-7. doi: 10.1111/jdi.12137.

4.

The difference of glucostatic parameters according to the remission of diabetes after Roux-en-Y gastric bypass.

Kim MK, Lee HC, Lee SH, Kwon HS, Baek KH, Kim EK, Lee KW, Song KH.

Diabetes Metab Res Rev. 2012 Jul;28(5):439-46. doi: 10.1002/dmrr.2297.

PMID:
22407971
5.

Safety and efficacy of Roux-en-Y gastric bypass to treat type 2 diabetes mellitus in non-severely obese patients.

Boza C, Muñoz R, Salinas J, Gamboa C, Klaassen J, Escalona A, Pérez G, Ibañez L, Guzmán S.

Obes Surg. 2011 Sep;21(9):1330-6. doi: 10.1007/s11695-011-0463-5.

PMID:
21744283
6.

Remission of type 2 diabetes after Roux-en-Y gastric bypass is associated with greater weight loss.

Kadera BE, Lum K, Grant J, Pryor AD, Portenier DD, DeMaria EJ.

Surg Obes Relat Dis. 2009 May-Jun;5(3):305-9. doi: 10.1016/j.soard.2009.02.007.

PMID:
19460674
7.

Bariatric surgery-mediated weight loss and its metabolic consequences for type-2 diabetes.

Raghow R.

World J Diabetes. 2013 Jun 15;4(3):47-50. doi: 10.4239/wjd.v4.i3.47.

8.

Soluble CD40 ligand in morbidly obese patients: effect of body mass index on recovery to normal levels after gastric bypass surgery.

Baena-Fustegueras JA, Pardina E, Balada E, Ferrer R, Catalán R, Rivero J, Casals I, Lecube A, Fort JM, Vargas V, Peinado-Onsurbe J.

JAMA Surg. 2013 Feb;148(2):151-6. doi: 10.1001/jamasurgery.2013.419.

PMID:
23426590
9.

Bariatric surgery versus conventional medical therapy for type 2 diabetes.

Mingrone G, Panunzi S, De Gaetano A, Guidone C, Iaconelli A, Leccesi L, Nanni G, Pomp A, Castagneto M, Ghirlanda G, Rubino F.

N Engl J Med. 2012 Apr 26;366(17):1577-85. doi: 10.1056/NEJMoa1200111.

10.

The early effect of the Roux-en-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism.

Rubino F, Gagner M, Gentileschi P, Kini S, Fukuyama S, Feng J, Diamond E.

Ann Surg. 2004 Aug;240(2):236-42.

11.

Early and longer term effects of gastric bypass surgery on tissue-specific insulin sensitivity and beta cell function in morbidly obese patients with and without type 2 diabetes.

Camastra S, Gastaldelli A, Mari A, Bonuccelli S, Scartabelli G, Frascerra S, Baldi S, Nannipieri M, Rebelos E, Anselmino M, Muscelli E, Ferrannini E.

Diabetologia. 2011 Aug;54(8):2093-102. doi: 10.1007/s00125-011-2193-6.

PMID:
21614570
12.

Bowel habits after bariatric surgery.

Potoczna N, Harfmann S, Steffen R, Briggs R, Bieri N, Horber FF.

Obes Surg. 2008 Oct;18(10):1287-96. doi: 10.1007/s11695-008-9456-4.

PMID:
18327626
13.

Early effects of gastric bypass on endothelial function, inflammation, and cardiovascular risk in obese patients.

Brethauer SA, Heneghan HM, Eldar S, Gatmaitan P, Huang H, Kashyap S, Gornik HL, Kirwan JP, Schauer PR.

Surg Endosc. 2011 Aug;25(8):2650-9. doi: 10.1007/s00464-011-1620-6. Erratum in: Surg Endosc. 2011 Aug;25(8):2660.

PMID:
21416179
14.

Metabolite profiling identifies candidate markers reflecting the clinical adaptations associated with Roux-en-Y gastric bypass surgery.

Mutch DM, Fuhrmann JC, Rein D, Wiemer JC, Bouillot JL, Poitou C, Clément K.

PLoS One. 2009 Nov 19;4(11):e7905. doi: 10.1371/journal.pone.0007905.

15.

Changes in serum ghrelin predict weight loss after Roux-en-Y gastric bypass in rats.

Stylopoulos N, Davis P, Pettit JD, Rattner DW, Kaplan LM.

Surg Endosc. 2005 Jul;19(7):942-6.

PMID:
15920683
16.

Cholesterol absorption decreases after Roux-en-Y gastric bypass but not after gastric banding.

Pihlajamäki J, Grönlund S, Simonen M, Käkelä P, Moilanen L, Pääkkönen M, Pirinen E, Kolehmainen M, Kärjä V, Kainulainen S, Uusitupa M, Alhava E, Miettinen TA, Gylling H.

Metabolism. 2010 Jun;59(6):866-72. doi: 10.1016/j.metabol.2009.10.004.

PMID:
20015521
17.

Case-matched outcomes in bariatric surgery for treatment of type 2 diabetes in the morbidly obese patient.

Dorman RB, Serrot FJ, Miller CJ, Slusarek BM, Sampson BK, Buchwald H, Leslie DB, Bantle JP, Ikramuddin S.

Ann Surg. 2012 Feb;255(2):287-93. doi: 10.1097/SLA.0b013e318232b033.

PMID:
21975321
18.

Comparative effectiveness of bariatric surgery and nonsurgical therapy in adults with type 2 diabetes mellitus and body mass index <35 kg/m2.

Serrot FJ, Dorman RB, Miller CJ, Slusarek B, Sampson B, Sick BT, Leslie DB, Buchwald H, Ikramuddin S.

Surgery. 2011 Oct;150(4):684-91. doi: 10.1016/j.surg.2011.07.069.

PMID:
22000180
19.

Impact of weight-loss surgery and diabetes status on serum ALT levels.

Xourafas D, Ardestani A, Ashley SW, Tavakkoli A.

Obes Surg. 2012 Oct;22(10):1540-7. doi: 10.1007/s11695-012-0677-1.

20.

Long-term effects of sleeve gastrectomy and Roux-en-Y gastric bypass surgery on type 2 diabetes mellitus in morbidly obese subjects.

Jiménez A, Casamitjana R, Flores L, Viaplana J, Corcelles R, Lacy A, Vidal J.

Ann Surg. 2012 Dec;256(6):1023-9. doi: 10.1097/SLA.0b013e318262ee6b.

PMID:
22968072
Items per page

Supplemental Content

Support Center